Angiosarcoma Treatment Market Analysis

Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy)

Angiosarcoma treatment market from the surgery segment is anticipated to account for the largest revenue share during the forecast period. This is because the need for biopsies to study various types of cancer is increasing. It also helps in proper diagnosis and treatment and plays an important role in various types of cancer services. According to cancer statistics, in 2021, the American Cancer Society performed more than 1 million biopsies in the United States. Due to the prevalence of cancer globally, increased demand for cancer surgery has been reported in recent years. According to a study published in January 2021, indications for cancer surgery will increase by 5 million interventions (52%) from 2018 (90,65,000) to 2040 (1.38 ,21,000). Such increasing demand for cancer surgery is driving the growth in angiosarcoma treatment market share.

End-Users (Hospitals, Homecare, Ambulatory Care Centre)

Based on end user, the ambulatory care center segment is poised to be the fastest growing segment in the angiosarcoma treatment market. This may be due to the characteristics of ambulatory centers that provide patients with chemotherapy regimens in an inpatient setting and supportive care provided in an outpatient setting. There, instead of spending the night in a hospital bed, patients stay in a nearby hotel or in their homes while receiving daily treatment and supportive care in an outpatient care facility. Because of these facilities, most people prefer outpatient care centers to long-term hospital stays. The growing popularity of outpatient centers to treat various cancers is driving the growth of angiosarcoma treatments in the projected time period.

Our in-depth analysis of the global angiosarcoma treatment market includes the following segments: